EU Research & Innovation
Programme Opportunities

European Partnership for One Health/Antimicrobial Resistance (AMR)

_____________

Snapshot overview: Partnership for EU-wide synergies on AMR activities

_____________

Name: European Partnership for One Health/Antimicrobial Resistance (AMR)

_____________

Institution/ DG/ Agency responsible at EU-level:

  • European Commission Directorate General for Research and Innovation (DG RTD) (lead DG)
  • European Commission Directorate General for Food Safety and Public Health (DG SANTE)
  • European Commission Directorate General for Agriculture (DG AGRI)
  • European Commission Directorate General for Environment (DG ENVI)
  • European Commission Joint Research Centre (JRC)
  • European Commission Directorate General for Mobility and Transport (DG MOVE)

_____________

Work programme: 2023-2024 work programme

_____________

Programme: Co-funded European Partnership programme

_____________

Programme budget: TBD

_____________

Project budget:  The total indicative budget for the topic is EUR 1 million

_____________

Type of funding : Financial contribution from national/regional research funders required for joint transnational calls for proposals. The potential for in-kind contributions (person months, use of research infrastructures, services) could be explored.

_____________

Target participants:

  • Public health/ animal health/ environment research funders from EU Member States
  • Public funders at both national and regional level in the EU and countries associated with Horizon Europe
  • Private foundations
  • Philanthropy organisations
  • Universities

_____________

Programme scope: The proposal builds on the ERA-Net EXEDRA (ends in 2020) that supports the JPIAMR, and on the One Health EJP (ends in December 2022) and its objectives include:

  • Contribute to achieving the objectives of the European One Health Action Plan against AMR and the WHO Global Action Plan on AMR
  • Reduce the threat of AMR
  • Recognize and strengthen the holistic One Health approach
  • Reinforce Europe’s leading role in the fight against AMR by adding value to, and leveraging Member State actions
  • Decrease fragmentation by boosting alignment of national research, and funding research projects and initiatives and improving EU and global coordination of research activities as well as collaboration between international research initiatives
  • Provide economic incentives

_____________

Participant criteria: TBD

_____________

Project duration: 2023 – 2027

_____________

Average time from submission to project kick-off: TBD

_____________

R&D stage: TBD

_____________

Intellectual property: TBD

_____________

Project database: EEU Funding & Tender Opportunities portal – Single Electronic Data Interchange Area (SEDIA)

_____________

Status: Expected start date in 2023

_____________

Contact details & more information